166 related articles for article (PubMed ID: 37730636)
1. Combined inhibition of Bcl-2 family members and YAP induces synthetic lethality in metastatic gastric cancer with RASA1 and NF2 deficiency.
Kwon JW; Oh JS; Seok SH; An HW; Lee YJ; Lee NY; Ha T; Kim HA; Yoon GM; Kim SE; Oh PR; Lee SH; Voon DC; Kim DY; Park JW
Mol Cancer; 2023 Sep; 22(1):156. PubMed ID: 37730636
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of proprotein convertases activity results in repressed stemness and invasiveness of cancer stem cells in gastric cancer.
Zaafour A; Seeneevassen L; Nguyen TL; Genevois C; Nicolas N; Sifré E; Giese A; Porcheron C; Descarpentrie J; Dubus P; Khatib AM; Varon C
Gastric Cancer; 2024 Mar; 27(2):292-307. PubMed ID: 38280128
[TBL] [Abstract][Full Text] [Related]
3. Synthetic Lethality in PTEN-Mutant Prostate Cancer Is Induced by Combinatorial PI3K/Akt and BCL-XL Inhibition.
Ren W; Joshi R; Mathew P
Mol Cancer Res; 2016 Dec; 14(12):1176-1181. PubMed ID: 27590631
[TBL] [Abstract][Full Text] [Related]
4.
Hayashi T; Desmeules P; Smith RS; Drilon A; Somwar R; Ladanyi M
Clin Cancer Res; 2018 Mar; 24(6):1436-1447. PubMed ID: 29127119
[No Abstract] [Full Text] [Related]
5. Ajuba overexpression regulates mitochondrial potential and glucose uptake through YAP/Bcl-xL/GLUT1 in human gastric cancer.
Li H; Fu L; Liu B; Lin X; Dong Q; Wang E
Gene; 2019 Apr; 693():16-24. PubMed ID: 30690182
[TBL] [Abstract][Full Text] [Related]
6. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target.
Wang Y; Chen H; Liu W; Yan H; Zhang Y; Cheung AHK; Zhang J; Chen B; Liang L; Zhou Z; Wong CC; Wu WKK; Chan MWY; Cheng ASL; Ma BBY; Yu J; Lo KW; To KF; Kang W
Theranostics; 2022; 12(15):6509-6526. PubMed ID: 36185598
[No Abstract] [Full Text] [Related]
7. A novel treatment strategy for lapatinib resistance in a subset of HER2-amplified gastric cancer.
Ning G; Zhu Q; Kang W; Lee H; Maher L; Suh YS; Michaud M; Silva M; Kwon JY; Zhang C; Lee C
BMC Cancer; 2021 Aug; 21(1):923. PubMed ID: 34399705
[TBL] [Abstract][Full Text] [Related]
8. YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.
White SM; Avantaggiati ML; Nemazanyy I; Di Poto C; Yang Y; Pende M; Gibney GT; Ressom HW; Field J; Atkins MB; Yi C
Dev Cell; 2019 May; 49(3):425-443.e9. PubMed ID: 31063758
[TBL] [Abstract][Full Text] [Related]
9. NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
Yang H; Hall SRR; Sun B; Zhao L; Gao Y; Schmid RA; Tan ST; Peng RW; Yao F
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805359
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-31 activates the RAS pathway and functions as an oncogenic MicroRNA in human colorectal cancer by repressing RAS p21 GTPase activating protein 1 (RASA1).
Sun D; Yu F; Ma Y; Zhao R; Chen X; Zhu J; Zhang CY; Chen J; Zhang J
J Biol Chem; 2013 Mar; 288(13):9508-18. PubMed ID: 23322774
[TBL] [Abstract][Full Text] [Related]
11. Jianpi Yangzheng decoction suppresses gastric cancer progression via modulating the miR-448/CLDN18.2 mediated YAP/TAZ signaling.
Xu X; Li Y; Zhang R; Chen X; Shen J; Yuan M; Chen Y; Chen M; Liu S; Wu J; Sun Q
J Ethnopharmacol; 2023 Jul; 311():116450. PubMed ID: 37023839
[TBL] [Abstract][Full Text] [Related]
12. Loss of large tumor suppressor 1 promotes growth and metastasis of gastric cancer cells through upregulation of the YAP signaling.
Zhang J; Wang G; Chu SJ; Zhu JS; Zhang R; Lu WW; Xia LQ; Lu YM; Da W; Sun Q
Oncotarget; 2016 Mar; 7(13):16180-93. PubMed ID: 26921249
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic monoclonal antibody targeting of neuronal pentraxin receptor to control metastasis in gastric cancer.
Kanda M; Shimizu D; Sawaki K; Nakamura S; Umeda S; Miwa T; Tanaka H; Tanaka C; Hayashi M; Iguchi Y; Yamada S; Katsuno M; Kodera Y
Mol Cancer; 2020 Aug; 19(1):131. PubMed ID: 32847597
[TBL] [Abstract][Full Text] [Related]
14. A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis.
Kwon JW; Seok SH; Kim S; An HW; Choudhury AD; Woo SH; Oh JS; Kim JK; Voon DC; Kim DY; Park JW
Oncogene; 2023 Feb; 42(7):501-515. PubMed ID: 36526851
[TBL] [Abstract][Full Text] [Related]
15. In vivo CRISPR-Cas9 knockout screening using quantitative PCR identifies thymosin beta-4 X-linked that promotes diffuse-type gastric cancer metastasis.
An HW; Kim SY; Kwon JW; Seok SH; Woo SH; Kim DY; Park JW
Mol Carcinog; 2021 Sep; 60(9):597-606. PubMed ID: 34081824
[TBL] [Abstract][Full Text] [Related]
16. Generation of mice with a conditional allele of the p120 Ras GTPase-activating protein.
Lapinski PE; Bauler TJ; Brown EJ; Hughes ED; Saunders TL; King PD
Genesis; 2007 Dec; 45(12):762-7. PubMed ID: 18064675
[TBL] [Abstract][Full Text] [Related]
17. CRISPR screens identify a novel combination treatment targeting BCL-X
Jung HR; Oh Y; Na D; Min S; Kang J; Jang D; Shin S; Kim J; Lee SE; Jeong EM; An JY; Sung CO; Lee WS; Lee C; Cho SY
Oncogene; 2021 May; 40(18):3287-3302. PubMed ID: 33846570
[TBL] [Abstract][Full Text] [Related]
18. Selective sensitivity of EZH2 inhibitors based on synthetic lethality in ARID1A-deficient gastric cancer.
Yamada L; Saito M; Thar Min AK; Saito K; Ashizawa M; Kase K; Nakajima S; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Kono K
Gastric Cancer; 2021 Jan; 24(1):60-71. PubMed ID: 32506298
[TBL] [Abstract][Full Text] [Related]
19. Expression of the Hippo transducer TAZ in association with WNT pathway mutations impacts survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy.
Melucci E; Casini B; Ronchetti L; Pizzuti L; Sperati F; Pallocca M; De Nicola F; Goeman F; Gallo E; Amoreo CA; Sergi D; Terrenato I; Vici P; Di Lauro L; Diodoro MG; Pescarmona E; Barba M; Mazzotta M; Mottolese M; Fanciulli M; Ciliberto G; De Maria R; Buglioni S; Maugeri-Saccà M
J Transl Med; 2018 Feb; 16(1):22. PubMed ID: 29402328
[TBL] [Abstract][Full Text] [Related]
20. LncRNA H19-rich extracellular vesicles derived from gastric cancer stem cells facilitate tumorigenicity and metastasis via mediating intratumor communication network.
Zhao H; Jiang R; Zhang C; Feng Z; Wang X
J Transl Med; 2023 Apr; 21(1):238. PubMed ID: 37005676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
